Skip to content

LIFT-plug vs LIFT, a RCT Trial

Ligation of Intersphincteric Fistula Tract Versus Ligation of the Intersphincteric Fistula Tract Plus a Bioprosthetic Anal Fistula Plug Procedure in Patients With Transsphincteric Anal Fistula: Multicenter Prospective Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04310800
Acronym
LIFT 02
Enrollment
384
Registered
2020-03-17
Start date
2018-01-01
Completion date
2020-12-31
Last updated
2020-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Fistula, Anal Function, Healing Rate, LIFT-plug

Keywords

anorectal fistula, LIFT-plug, complications of treatment, healing rate, anal function

Brief summary

To validate the effect of Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug procedure for Anal Fistula Repair in 7 medical centers

Detailed description

The management of trans-sphincteric anal fistulae of cryptoglandular origin is challenging. The ideal management is to effectively heal the fistula without compromising continence, avoid fistula recurrence, and quick recovery. Ligation of the intersphincteric fistula tract (LIFT) and LIFT reinforced with a bioprosthetic graft (BioLIFT) are two recently reported procedures that showed improved healing results. In the LIFT, Rojanasakul et al proposed to identify the fistula tract in the intersphincteric space and subsequent division and ligation of the tract, and the primary healing rate was 94.4%. The following studies reported slightly lower results, but the recurrence rate was as high as 18% to 28%. Ellis et al subsequently described a modified LIFT procedure (BioLIFT procedure) in which a bioprosthetic was placed in the intersphincteric plane to reinforce the closure of the fistula tract (BioLIFT procedure), and yielded a healing rate of 94% in 31 patients who had a minimum of 1 year of follow-up after their last treatment. The investigators modified the LIFT procedure by combining LIFT with the technique of anal fistula plug. The bioprosthetic plug was placed into the fistula tract through the opening in the external sphincter to the external opening in the skin after LIFT procedure. The present study was designed to assess the preliminary results of LIFT-Plug technique prospectively. The purpose of this study is to validate the effect of Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug procedure for Anal Fistula Repair in 7 medical centers.

Interventions

PROCEDURELIFT-plug technique

Small-intestine submucosa extracellular matrix plug was soaked in saline for 5-10 min, then placed into the intersphincteric groove and pulled through the curetted tract to the external opening. The plug was secured with a figure-of-eight 3/0 absorbable suture to the fistula opening in the external sphincter and ligated. Excess plug protruding from the external opening was trimmed flush with the skin without fixation. The wound was loosely closed with 2-3 interrupted 3/0 absorbable sutures

Sponsors

The Second Artillery General Hospital
CollaboratorOTHER
Peking University Third Hospital
CollaboratorOTHER
Beijing Anorectal Hospital
CollaboratorOTHER
Beijing Luhe Hospital
CollaboratorOTHER
Beijing Shuyi Hospital
CollaboratorOTHER
People's Hospital of Beijing Daxing District
CollaboratorOTHER
Zhen Jun Wang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Randomization was performed on the day before surgery through sealed opaque envelopes containing the surgical method. The study was approved by the institutional review boards of the 7 hospitals.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* High transsphincteric fistula (involving \> 30% of the external anal sphincter) * Age between 18 and 70 years * Chronic anal fistula with fistula tracts no more than 2 * No active sepsis or abscess

Exclusion criteria

* Fistulas with active inflammation or purulence * Fistulas related to tumor, Crohn's disease, tuberculosis or acquired immune deficiency syndrome * Poorly controlled diabetes with fasting blood-glucose \> 8mmol/L * Preexisting incontinence * Multiple fistula tracts \> 2 * Fasting blood-glucose ≥ 8mmol/L * Allergic or contraindication for the use of animal protein * Pregnant women * Expected life less than 6 months * With anorectal abscess * Serious liver (Child-Pugh C) and chronic kidney disease (CKD) stage 3

Design outcomes

Primary

MeasureTime frameDescription
Healing rate6 months postoperativelythe healing rate of two groups in 6 months postoperatively
healing time6 months postoperativelythe wound healing time from operation to healing

Secondary

MeasureTime frameDescription
pain score postoperatively5 days, 2 weeks, 1 months, 3 months and 1 year postoperativelyvisual analog scale scores
anal function5 days, 2 weeks, 1 months, 3 months and 1 year postoperativelywexner score

Countries

China

Contacts

Primary ContactJinjie Cui, MD
913916215@qq.com+86 10 85231604

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026